Medibank Private (ASX:MPL) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Medibank Private 3-Year EBITDA Growth Rate?

Medibank Private's EBITDA per Share for the six months ended in Dec. 2023 was A$0.19.

During the past 12 months, Medibank Private's average EBITDA Per Share Growth Rate was 41.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Competitive Comparison of Medibank Private's 3-Year EBITDA Growth Rate

For the Insurance - Specialty subindustry, Medibank Private's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medibank Private's 3-Year EBITDA Growth Rate Distribution in the Insurance Industry

For the Insurance industry and Financial Services sector, Medibank Private's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Medibank Private's 3-Year EBITDA Growth Rate falls into.

Medibank Private 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Medibank Private (ASX:MPL) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Medibank Private 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Medibank Private's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medibank Private (ASX:MPL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Medibank Private Ltd (ASX:MPL) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

MDBPF:USA

Address

720 Bourke Street, Level 6, Docklands, VIC, AUS, 3008

Website

https://www.medibank.com.au

Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund NIB Holdings are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.

Medibank Private (ASX:MPL) Headlines

No Headlines